Cite
HARVARD Citation
Tuttle, K. et al. (2019). Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7). Diabetes, obesity & metabolism. 21 (6), pp. 1493-1497. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tuttle, K. et al. (2019). Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7). Diabetes, obesity & metabolism. 21 (6), pp. 1493-1497. [Online].